We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$4.96B
AUM Growth
-$641M
Cap. Flow
-$193M
Cap. Flow %
-3.9%
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$33.6M
2
AMZN icon
Amazon
AMZN
+$32.3M
3
CEB
CEB Inc.
CEB
+$27.7M
4
GILD icon
Gilead Sciences
GILD
+$27.3M
5
MRK icon
Merck
MRK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.16%
2 Financials 16.84%
3 Consumer Discretionary 14.26%
4 Technology 13.32%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RHI icon
51
Robert Half
RHI
$4.6B
$32.4M 0.65%
632,592
-142,737
-18% -$7.68M
NXPI icon
52
NXP Semiconductors
NXPI
$57B
$32.1M 0.65%
369,045
+106,386
+41% +$9.59M
CPAY icon
53
Corpay
CPAY
$26.5B
$31M 0.63%
225,608
+1,234
+0.5% +$189K
CAH icon
54
Cardinal Health
CAH
$54.7B
$29.5M 0.6%
384,120
-8,811
-2% -$736K
SCU
55
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$29.3M 0.59%
336,116
-118,415
-26% -$12.7M
ARMH
56
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$29.3M 0.59%
677,165
-84,145
-11% -$3.75M
BMY icon
57
Bristol-Myers Squibb
BMY
$137B
$28M 0.56%
472,769
-14,112
-3% -$895K
CVS icon
58
CVS Health
CVS
$119B
$28M 0.56%
290,068
+15,389
+6% +$1.62M
NKE icon
59
Nike
NKE
$57B
$27.5M 0.56%
447,620
+425,484
+1,922% +$24.1M
CEB
60
DELISTED
CEB Inc.
CEB
$27.3M 0.55%
400,031
+359,220
+880% +$27.7M
UPS icon
61
United Parcel Service
UPS
$89.9B
$27M 0.55%
273,977
-5,882
-2% -$581K
APAM icon
62
Artisan Partners
APAM
$3.09B
$26.4M 0.53%
749,917
-39,565
-5% -$1.71M
CTSH icon
63
Cognizant
CTSH
$28.7B
$25.1M 0.51%
400,672
+35,770
+10% +$2.25M
SUN icon
64
Sunoco
SUN
$14.2B
$24.3M 0.49%
718,667
-569,027
-44% -$21.8M
CNC icon
65
Centene
CNC
$32.3B
$24.1M 0.49%
889,324
-204,488
-19% -$6.84M
MRK icon
66
Merck
MRK
$369B
$23.5M 0.47%
498,070
+473,608
+1,936% +$25.2M
EWBC icon
67
East-West Bancorp
EWBC
$17.8B
$23.5M 0.47%
610,718
+184,034
+43% +$7.78M
SLB icon
68
SLB Ltd
SLB
$81.6B
$20.8M 0.42%
301,458
+212,579
+239% +$16.8M
HCA icon
69
HCA Healthcare
HCA
$90.8B
$20.8M 0.42%
268,707
+84,263
+46% +$7.46M
NOW icon
70
ServiceNow
NOW
$143B
$20.7M 0.42%
1,492,540
+37,095
+3% +$554K
EQM
71
DELISTED
EQM Midstream Partners, LP
EQM
$20.3M 0.41%
306,422
+97,880
+47% +$7.4M
SHW icon
72
Sherwin-Williams
SHW
$83.8B
$20.1M 0.41%
270,939
+3,702
+1% +$325K
CBRE icon
73
CBRE Group
CBRE
$42.6B
$19.9M 0.4%
621,178
+13,110
+2% +$465K
MKTX icon
74
MarketAxess Holdings
MKTX
$5.72B
$19M 0.38%
204,981
+148,170
+261% +$14.3M
BIP icon
75
Brookfield Infrastructure Partners
BIP
$17.9B
$18.1M 0.37%
1,242,410
-76,921
-6% -$1.24M

Similar funds

Geneva Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.

  • Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
  • Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
  • Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
  • Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
  • Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
  • Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
  • Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.

Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.